Farhad Hafezi

The ELZA Institute’s surgeons and researchers spent four days in Vienna at the 36th Congress of the ESCRS, and went to the meeting with a busy schedule!
Why did the Serbian military offer to fly Prof. Farhad Hafezi in a helicopter to a ski resort in early September? After all, the slopes were green with grass, not white with snow.
Presenting to the Swiss Optometrists Association (SBAO) Annual Meeting, Hafezi identified the single biggest villain in the development of keratoconus: eye rubbing.
Other vision healthcare professionals regularly refer patients to ELZA who have “challenging corneas”; many are those whose original laser refractive surgery didn’t quite go to plan, and they need re-treatment to fix their vision
Children: to cross-link or not to cross-link? If a person is going to develop keratoconus, that person is more likely to be a child than an adult.
Keratoconus is the progressive thinning of the cornea, and corneal cross-linking (CXL) can successfully treat it.
Prof. Hafezi in a video interview with EyeWorld at the World Ophthalmology Congress 2018 in Barcelona about the relationship between thyroid hormone and changes in the cornea and in vision.
Prof. Hafezi in a controversy about Cross-Linking with Prof. Damien Gatinel at the Science2Clinix-Kongress in Bangalore. 
The ELZA Institute was part of the main lecture program of the 2018 congress of the German ophthalmic surgeons, DOC in Nuremberg.
Prof. Hafezi gives an overview at Science2Clinix 2018 in Bangalore about ELZA’s latest research results on corneal cross-linking research.
.
.